Biopharmaceutical Excipients Market By Product - Global Industry Analysis And Forecast To 2027
Published On : March 2019 Pages : 170 Category: Pharmaceuticals Report Code : HC033022
Biopharmaceutical Excipients Market By Product (Specialty Biopharmaceutical Excipients, Solubilizers & Surfactants/Emulsifiers, Carbohydrates and Polyols) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The Biopharmaceutical Excipients are critical to medication conveyance inside the body. For the most part, the excipient has no therapeutic properties. Its main purpose is for streamlining the production of the medication item and at last encourage physiological retention of the medication. They may help for disintegration, taste, lubricity, flow ability and may give some type of the antimicrobial capacity. Therefore, the Biopharmaceutical Excipients Market is anticipated to expand and has tremendous scope during the forecast period. The global Biopharmaceutical Excipients Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
By Product the market is segmented into Specialty Biopharmaceutical Excipients, Solubilizers & Surfactants/Emulsifiers, Carbohydrates and Polyols. The Carbohydrates section is leading the market due to ease of products availability, conventional utilization of starch for manufacturing of various drug products, etc.
Regional Insights
The European region is leading the global Biopharmaceutical Excipients Market followed by the North American region owing to diversified suppliers present in this region, more funding in the chemicals sector and some other factors.
Biopharmaceutical Excipients Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Bupa Cromwell Hospital
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Biopharmaceutical Excipients Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Specialty Biopharmaceutical Excipients
o Solubilizers & Surfactants/Emulsifiers
o Carbohydrates
o Polyols
o Biopharmaceutical Excipients Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o BASF SE
o IMCD
o Merck KGaA
o Pharmonix
o JRS PHARMA
o Signet Chemical Corporation Pvt. Ltd.
o SPI Pharma
o Sigachi Industries Pvt. Ltd.
o Spectrum Chemical Manufacturing Corp.
o DFE Pharma
o Roquette
o Biopharmaceutical Excipients Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Biopharmaceutical Excipients Market, By Country
o U.S. Biopharmaceutical Excipients Market
o Canada Biopharmaceutical Excipients Market
o Mexico Biopharmaceutical Excipients Market
o Europe
§ Europe Biopharmaceutical Excipients Market, By Country
o Germany Biopharmaceutical Excipients Market
o UK Biopharmaceutical Excipients Market
o France Biopharmaceutical Excipients Market
o Russia Biopharmaceutical Excipients Market
o Italy Biopharmaceutical Excipients Market
o Rest of Europe Biopharmaceutical Excipients Market
o Asia-Pacific
§ Asia-Pacific Biopharmaceutical Excipients Market, By Country
o China Biopharmaceutical Excipients Market
o Japan Biopharmaceutical Excipients Market
o South Korea Biopharmaceutical Excipients Market
o India Biopharmaceutical Excipients Market
o Southeast Asia Biopharmaceutical Excipients Market
o Rest of Asia-Pacific Biopharmaceutical Excipients Market
o South America
§ South America Biopharmaceutical Excipients Market, By Country
o Brazil Biopharmaceutical Excipients Market
o Argentina Biopharmaceutical Excipients Market
o Columbia Biopharmaceutical Excipients Market
o Rest of South America Biopharmaceutical Excipients Market
o Middle East and Africa
§ Middle East and Africa Biopharmaceutical Excipients Market, By Country
o Saudi Arabia Biopharmaceutical Excipients Market
o UAE Biopharmaceutical Excipients Market
o Egypt Biopharmaceutical Excipients Market
o Nigeria Biopharmaceutical Excipients Market
o South Africa Biopharmaceutical Excipients Market
o Rest of MEA Biopharmaceutical Excipients Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Biopharmaceutical Excipients Market, By Product
5.1. Introduction
5.2. Global Biopharmaceutical Excipients Revenue and Market Share by Product (2017-2027)
5.2.1. Global Biopharmaceutical Excipients Revenue and Revenue Share by Product (2017-2027)
5.3. Specialty Biopharmaceutical Excipients
5.3.1. Global Specialty Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
5.4. Solubilizers & Surfactants/Emulsifiers
5.4.1. Global Solubilizers & Surfactants/Emulsifiers Revenue and Growth Rate (2017-2027)
5.5. Carbohydrates
5.5.1. Global Carbohydrates Revenue and Growth Rate (2017-2027)
5.6. Polyols
5.6.1. Global Polyols Revenue and Growth Rate (2017-2027)
6. Biopharmaceutical Excipients Market, By Region
6.1. Introduction
6.2. Global Biopharmaceutical Excipients Revenue and Market Share by Regions
6.2.1. Global Biopharmaceutical Excipients Revenue by Regions (2017-2027)
6.3. North America Biopharmaceutical Excipients by Countries
6.3.1. North America Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
6.3.2. North America Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Biopharmaceutical Excipients by Countries
6.4.1. Europe Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
6.4.2. Europe Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Biopharmaceutical Excipients by Countries
6.5.1. Asia-Pacific Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Biopharmaceutical Excipients by Countries
6.6.1. South America Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
6.6.2. South America Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Biopharmaceutical Excipients by Countries
6.7.1. Middle East and Africa Biopharmaceutical Excipients Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. BASF SE
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. IMCD
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Merck KGaA
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Pharmonix
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. JRS PHARMA
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Signet Chemical Corporation Pvt. Ltd.
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. SPI Pharma
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. Sigachi Industries Pvt. Ltd.
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. Spectrum Chemical Manufacturing Corp.
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
7.10. DFE Pharma
7.10.1. Business Overview
7.10.2. Service Portfolio
7.10.3. Strategic Developments
7.10.4. Financial Overview
7.11. Roquette
7.11.1. Business Overview
7.11.2. Service Portfolio
7.11.3. Strategic Developments
7.11.4. Financial Overview
8. Global Biopharmaceutical Excipients Market Competition, by Manufacturer
8.1. Global Biopharmaceutical Excipients Revenue and Market Share by Manufacturer (2017-2017)
8.2. Global Biopharmaceutical Excipients Price By Region (2017-2017)
8.3. Top 5 Biopharmaceutical Excipients Manufacturer Market Share
8.4. Market Competition Trend
9. Biopharmaceutical Excipients Market Forecast (2017-2027)
9.1. Global Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Biopharmaceutical Excipients Market Forecast by Regions (2017-2027)
9.2.1. North America Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.1.1. United States Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.1.2. Canada Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.1.3. Mexico Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2. Europe Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.1. Germany Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.2. France Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.3. UK Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.4. Russia Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.5. Italy Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3. Asia-Pacific Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.1. China Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.2. Japan Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.3. Korea Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.4. India Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.4. South America Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.4.1. Brazil Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.4.2. Argentina Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.4.3. Columbia Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.4.4. Rest of South America Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5. Middle East and Africa Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.3. Egypt Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.4. Nigeria Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.5. South Africa Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.6. Turkey Biopharmaceutical Excipients Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Biopharmaceutical Excipients Market Forecast (2017-2027)
9.3. Biopharmaceutical Excipients Market Forecast by Product (2017-2027)
9.3.1. Biopharmaceutical Excipients Forecast by Product (2017-2027)
9.3.2. Biopharmaceutical Excipients Market Share Forecast by Product (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Biopharmaceutical Excipients Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Biopharmaceutical Excipients Revenue and Revenue Share by Product (2017-2018)
Figure Global Specialty Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure Global Solubilizers & Surfactants/Emulsifiers Revenue and Growth Rate (2017-2018)
Figure Global Carbohydrates Revenue and Growth Rate (2017-2018)
Figure Global Polyols Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceutical Excipients Revenue by Regions (2017-2018)
Figure North America Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure North America Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure North America Biopharmaceutical Excipients by Countries (2017-2018)
Figure North America Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2018)
Figure United States Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure United States Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Canada Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Mexico Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Europe Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure Europe Biopharmaceutical Excipients by Countries (2017-2018)
Figure Europe Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2018)
Figure Germany Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Germany Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure France Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure UK Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Russia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Italy Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceutical Excipients by Countries (2017-2018)
Figure Asia-Pacific Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2018)
Figure China Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure China Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Japan Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Korea Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure India Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure South America Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure South America Biopharmaceutical Excipients by Countries (2017-2018)
Figure South America Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Brazil Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Argentina Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Columbia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical Excipients Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceutical Excipients by Countries (2017-2018)
Figure Middle East and Africa Biopharmaceutical Excipients Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Saudi Arabia Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Egypt Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Nigeria Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure South Africa Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Turkey Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceutical Excipients Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2017-2018)
Table BASF SE Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IMCD Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck KGaA Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pharmonix Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table JRS PHARMA Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Signet Chemical Corporation Pvt. Ltd. Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table SPI Pharma Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sigachi Industries Pvt. Ltd. Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Spectrum Chemical Manufacturing Corp. Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table DFE Pharma Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Roquette Biopharmaceutical Excipients Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Biopharmaceutical Excipients Market Share by Manufacturer
Figure Global Biopharmaceutical Excipients Revenue and Market Share by Manufacturer
Table Global Biopharmaceutical Excipients Price by Region (2017-2017)
Figure Top 5 Biopharmaceutical Excipients Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Biopharmaceutical Excipients Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biopharmaceutical Excipients Market Forecast by Regions (2018-2025)
Figure North America Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure United States Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Canada Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Mexico Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Europe Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Germany Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure France Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure UK Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Russia Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Italy Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Rest of Europe Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Asia-Pacific Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure China Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Japan Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Korea Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure India Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Southeast Asia Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure South America Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Brazil Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Argentina Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Columbia Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Rest of South America Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Middle East and Africa Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Saudi Arabia Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure United Arab Emirates Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Egypt Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Nigeria Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure South Africa Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Turkey Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biopharmaceutical Excipients Market Forecast (2018-2025)
Figure Global Biopharmaceutical Excipients Forecast by Product (2018-2025)
Figure Global Biopharmaceutical Excipients Market Share Forecast by Product (2018-2025)
Figure Global Biopharmaceutical Excipients Forecast by Product (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|